Keyphrases
Confidence Interval
100%
Tuberculous Pericarditis
99%
Hazard Ratio
76%
Black African
74%
Rheumatic Heart Disease
74%
Atrial Fibrillation
67%
South Africa
59%
Africa
53%
Sub-Saharan Africa
50%
Disease Registry
49%
Multicenter Trial
49%
Prednisolone
49%
Pericarditis
49%
Warfarin
49%
Placebo
47%
Hypertension Guidelines
31%
Idiopathic Dilated Cardiomyopathy
31%
Academic Hospital
31%
Clinical Outcomes
30%
Moderate to Severe
29%
Oral Anticoagulation
29%
AIDS/HIV
28%
New-onset Atrial Fibrillation
28%
Black South African Patients
27%
Heart Failure
27%
Systolic Blood Pressure
26%
GARFIELD
24%
1-year Outcome
24%
Hypertension
24%
2-year Follow-up
24%
Chronic Kidney Disease
24%
Patient Management
24%
Evidence-based Interventions
24%
Combination Therapy
24%
Genetic Variants
24%
Cardiac Pacing
24%
Randomized Double-blind
24%
Pacemaker
24%
Pharmacokinetics
24%
Heart Failure with Preserved Ejection Fraction (HFpEF)
24%
Initial Management
24%
Mycobacterium Indicus Pranii
24%
Genetic Markers
24%
Polymorphism
24%
Aspirin
24%
Ventricular Arrhythmia
24%
CYP2C9
24%
Mycobacterium w
24%
Supratherapeutic INR
24%
Mechanical Heart Valve Prostheses
24%
Medicine and Dentistry
Tuberculous Pericarditis
99%
Hazard Ratio
76%
Rheumatic Heart Disease
74%
Atrial Fibrillation
65%
Congestive Heart Failure
50%
Mycobacterium Indicus Pranii
49%
Pericarditis
49%
Prednisolone
49%
Disease
39%
Placebo
39%
Immunotherapy
33%
Apoplexy
32%
Anticoagulation
29%
Human Immunodeficiency Virus
28%
Chronic Kidney Disease
24%
Diabetic Hypertension
24%
Pacemaker Implantation
24%
Heart Pacing
24%
Arrhythmia
24%
Nonischemic Cardiomyopathy
24%
Heart Valve Prosthesis
24%
Warfarin
24%
Mechanical Heart Valve
24%
Randomized Controlled Trial
24%
Ejection Fraction
24%
Diabetes Mellitus
24%
Systolic Blood Pressure
24%
Self Concept
24%
Low and Middle Income Countries
24%
Implant
24%
Retrospective Study
24%
Electrocardiogram
24%
Blood Pressure
24%
Myocardial Disease
24%
Antihypertensive Agent
24%
Antithrombotic
24%
Tamponade
23%
Ischemic Cardiomyopathy
23%
Constrictive Pericarditis
22%
Prothrombin Time
21%
Human Immunodeficiency Virus Infection
21%
Rheumatic Fever
19%
Mortality Rate
17%
Pericardiocentesis
17%
Clinical Feature
17%
Hemodynamic
16%
Atrioventricular Block
16%
Health Care
16%
Diagnosis
13%
Patient Referral
12%